Pulmonary Veins: Anatomy, Function, and AFib Link

Pulmonary veins are the blood vessels that carry freshly oxygenated blood from the lungs back to the heart’s left atrium, making them unique among veins: while almost every other vein in the body transports oxygen-poor blood, pulmonary veins deliver the richest oxygen supply your circulation has to offer. Most people have four of them, two draining each lung, but anatomical variations are common and carry real clinical consequences, particularly for anyone facing treatment for atrial fibrillation or born with a congenital heart defect.

Basic Anatomy and Why Variation Is the Norm

In the standard textbook layout, you have a left superior and left inferior pulmonary vein draining the left lung, and a right superior and right inferior pulmonary vein draining the right lung. All four empty individually into the left atrium at the back of the heart. A systematic review of pulmonary vein anatomy confirmed that this “classical” pattern with four separate openings is the most common arrangement, but it also found significant variability across the population.¹

How common is variation? A CT-based study found that only about two-thirds of people on the right side and about 82% on the left side had the expected two-vein-per-side arrangement. On the right side alone, researchers identified 13 different drainage patterns.² Some people have two veins that merge into a single trunk before reaching the atrium (a “conjoined” vein), while others have extra veins that open separately, sometimes called supernumerary veins. Neither situation is inherently dangerous, but both matter enormously when a cardiologist plans a catheter procedure and needs to know exactly how many openings to target.³

How Pulmonary Veins Form Before Birth

During embryonic development, the pulmonary veins start as a single channel that tunnels through the tissue between the developing lungs and the heart. This solitary vein connects the lung’s venous networks to the heart by way of a structure called the dorsal mesocardium, essentially a bridge of tissue at the back of the embryonic heart. As development progresses, the opening of that single vein gets committed to the left atrium, and the vessel branches and is gradually incorporated into the atrial wall so that the four separate openings seen in adults take shape.⁴ Crucially, the pulmonary vein develops independently from the systemic venous system (the veins that drain the rest of the body into the right atrium). When this separation goes wrong during fetal life, the result can be one of several congenital malformations discussed below.

Myocardial Sleeves and the Connection to Atrial Fibrillation

One of the most clinically important features of pulmonary veins is something you cannot see from the outside: extensions of heart muscle that wrap around the veins where they meet the left atrium. These so-called myocardial sleeves are present in the vast majority of pulmonary veins. A postmortem study of 100 hearts (393 individual veins) found sleeves in about 89% of the veins examined.⁵ These muscle sleeves are electrically active, meaning they can generate their own electrical impulses and, under the right conditions, fire off rapid, chaotic signals that hijack the heart’s normal rhythm.

This is exactly what happens in many cases of atrial fibrillation, the most common sustained heart rhythm disorder. A landmark study published in the New England Journal of Medicine mapped the origins of the abnormal electrical beats that trigger atrial fibrillation in 45 patients. Of the 69 triggering foci identified, 94% originated inside the pulmonary veins, with the earliest abnormal signal detected about two to four centimeters inside the vein. The fibrillation typically started with a sudden burst of rapid firing.⁶ A subsequent study of 79 patients confirmed similar numbers, finding that roughly 89% of the ectopic foci causing atrial fibrillation came from pulmonary veins.⁷

The autonomic nervous system plays a role too. Clusters of nerve cells called ganglionated plexi sit on the surface of the heart near the pulmonary vein openings. Research has shown that stimulating these nerve clusters promotes the initiation and maintenance of atrial fibrillation, and patients with atrial fibrillation tend to have more active ganglionated plexi than people without the condition.⁸ One study found that AF patients had significantly more sites producing strong nerve-mediated responses compared to non-AF patients, suggesting the nerve activity is not just incidental but part of the disease substrate.⁹

Pulmonary Vein Isolation for Atrial Fibrillation

The discovery that pulmonary veins are the main culprit behind atrial fibrillation led directly to a treatment strategy: electrically disconnect the veins from the rest of the heart. This procedure, called pulmonary vein isolation, has become the cornerstone of catheter-based atrial fibrillation treatment. A catheter is threaded through a vein, usually in the groin, up into the heart, and then through the wall between the right and left atria. The operator then delivers energy around each pulmonary vein opening to create a ring of scar tissue that blocks the rogue electrical signals from escaping into the atrium.

Early results from one of the pioneering series showed that in 70 patients who underwent the procedure, about 94% of targeted veins were successfully isolated. At five months of follow-up, 70% of patients with the paroxysmal (intermittent) form of atrial fibrillation were free of recurrence without drugs.¹⁰ Outcomes were notably worse for patients with persistent atrial fibrillation, where only about 22% stayed arrhythmia-free, a gap that still challenges electrophysiologists today.

The Achilles’ heel of pulmonary vein isolation is reconnection. Over weeks to months, gaps in the scar line can heal, allowing electrical signals to sneak through again. A randomized trial comparing two common energy sources, radiofrequency (heat) and cryoballoon (freezing), found that roughly three-quarters to four-fifths of previously isolated veins remained disconnected at follow-up, with no significant difference between the two approaches across any of the four veins.¹¹ The location of gaps does differ between techniques, however, which can influence the strategy if a redo procedure is needed.¹²

Pulsed Field Ablation and the Safety Problem It Aims to Solve

Both radiofrequency and cryoballoon ablation create lesions through temperature extremes, and the tissue around pulmonary veins is a crowded neighborhood. The esophagus sits just behind the left atrium, the phrenic nerve runs nearby, and the veins themselves can be damaged. Thermal energy does not discriminate between heart muscle and these neighboring structures, which is why a newer technology, pulsed field ablation, has generated excitement.

Pulsed field ablation uses ultrashort, high-voltage electrical pulses that destroy heart muscle cells by punching holes in their membranes (a process called electroporation) without generating significant heat. The key advantage is tissue selectivity: heart muscle is highly susceptible to this kind of injury, while the esophagus, phrenic nerves, pulmonary veins, and coronary arteries are relatively resistant.¹³ In an early clinical study of 81 patients, all pulmonary veins were successfully isolated, procedure times averaged about 92 minutes, and the 12-month freedom from arrhythmia was roughly 87%. Beyond one case of pericardial tamponade (fluid around the heart from a puncture), there were no strokes, no phrenic nerve injuries, no esophageal injuries, and no vein narrowing.¹⁴

The absence of pulmonary vein stenosis in that series is worth highlighting. Pulmonary vein stenosis, where the vein narrows after ablation because of scarring and tissue thickening at the treatment site, has been a recognized complication of traditional ablation. The damage can lead to fibrosis, thickening of the inner vessel wall, and even blood clot formation inside the vein.¹⁵ While modern technique improvements have made severe stenosis rare, pulsed field ablation’s tissue selectivity may reduce the risk further still.

Congenital Anomalies of the Pulmonary Veins

When the embryonic connection between pulmonary veins and the left atrium fails to form correctly, the result is an anomalous pulmonary venous connection. The severity ranges widely. In partial anomalous pulmonary venous return (PAPVR), one or two veins drain to the wrong chamber, often the right atrium or one of the large systemic veins. Some people with PAPVR live for decades without symptoms, sometimes diagnosed only when imaging for another issue reveals a dilated right heart or an unusual blood-oxygen pattern. One reported case involved a 61-year-old man whose shortness of breath had been attributed to pulmonary hypertension before an anomalous right superior pulmonary vein was found draining into the wrong location alongside a sinus venosus atrial septal defect.¹⁶

Total anomalous pulmonary venous return (TAPVR) is far more dangerous. Here, none of the pulmonary veins connect to the left atrium. Instead, all oxygenated blood from the lungs detours into the right side of the heart or into a systemic vein, and the baby survives only because a hole between the atria allows some oxygenated blood to reach the left side. TAPVR is a surgical emergency in the newborn period. The condition appears connected to both genetic and environmental factors: it has been reported with autosomal dominant inheritance patterns with variable expression and incomplete penetrance, and it appears alongside heterotaxy syndrome and several other genetic conditions. Disruption of many developmental pathways can lead to partial or total pulmonary venous misconnections. Unusual subtypes continue to be described in the literature, including a recently reported case of mixed drainage through a vertical vein with simultaneous cardiac and infracardiac connections, a pattern not previously documented.¹⁷

Pulmonary Vein Thrombosis

Blood clots forming inside a pulmonary vein are uncommon, and that rarity is part of the problem: the condition is often missed because its symptoms (cough, coughing up blood, shortness of breath) overlap with many more common lung conditions.¹⁸ The most common risk factors are cancer and cancer-related lung surgery. A clinical series found that cancer was present in over half of patients diagnosed with pulmonary vein thrombosis, and surgical lobectomy, particularly removal of the left upper lobe, accounted for about a fifth of cases. External compression of the vein and recent surgery of other kinds were also common triggers, and roughly one in five cases had no identifiable cause.¹⁹

The consequences of a missed diagnosis can be serious. A clot sitting in a pulmonary vein is upstream of the left atrium and therefore the entire systemic arterial circulation. If a piece breaks off, it can travel to the brain and cause a stroke. In the same clinical series, the four-year probability of experiencing a left atrial thrombus was about 21%, and the probability of ischemic stroke was about 9%.²⁰ Diagnosis usually requires advanced imaging such as CT, MRI, or echocardiography, and the key ingredient is clinical suspicion: thinking of the condition in the first place.

Pulmonary Veno-Occlusive Disease

A separate and rarer disorder affecting pulmonary veins is pulmonary veno-occlusive disease (PVOD). Unlike thrombosis, which involves a clot, PVOD is a progressive condition in which the small veins and venules within the lung undergo fibrotic thickening of their inner walls, gradually narrowing or completely blocking them. The hallmark finding is diffuse involvement of the smallest post-capillary venules, with concentric fibrosis mainly affecting veins smaller than a tenth of a millimeter in diameter. Total blockage and various stages of recanalization (the body’s attempt to re-open the vessels) are commonly seen under the microscope.²¹

PVOD is often lumped in with pulmonary arterial hypertension because both cause high pressures in the lung circulation and similar symptoms of breathlessness and exercise intolerance. The critical difference is treatment response: the vasodilator drugs used for pulmonary arterial hypertension can be dangerous in PVOD, because opening the arteries while the veins remain blocked floods the lung capillaries with blood and can trigger fatal pulmonary edema. Distinguishing PVOD from arterial hypertension requires careful imaging and sometimes lung biopsy. Moderate fibrotic changes in pulmonary veins can show up in other conditions such as long-standing mitral valve disease, so the massive, diffuse involvement of small venules is what clinicians look for to nail down the PVOD diagnosis.²²

The Veins as Active Regulators, Not Passive Pipes

It is tempting to think of pulmonary veins as simple conduits, but they actively participate in controlling blood flow through the lungs. At birth, the veins relax in response to signals from their inner lining, including nitric oxide and dilator prostaglandins, helping to lower the resistance in the lung’s blood vessels as the newborn takes its first breaths. Under chronic low-oxygen conditions, pulmonary veins can remodel and constrict substantially, and in humans and several other species they are a primary site of action for potent constrictors like endothelin and thromboxane.²³

Clinicians also exploit the flow patterns within pulmonary veins as a diagnostic window. Doppler ultrasound of pulmonary venous flow can provide clues about pressures inside the left atrium. In patients with acute heart attacks, the speed at which the diastolic flow wave decelerates in the pulmonary vein has been shown to track very closely with left-atrial filling pressure: a short deceleration time predicts elevated pressure with high accuracy.²⁴ This means that in some clinical scenarios, imaging the pulmonary veins can tell you about the state of the left heart without having to thread a catheter into the chest.

Pulmonary Veins in Lung Transplantation

When a single lung is transplanted, the surgeon needs to connect the donor lung’s pulmonary veins to the recipient’s left atrium. In a typical double-lung transplant, there is ample atrial tissue on both sides, but in a single-lung transplant the cuff of left-atrial tissue surrounding the donor veins can be small and awkward to sew. One technique described in the surgical literature involves creating a “neoatrial cuff” by suturing the edges of the donor’s two pulmonary veins to the pericardium (the sac naturally surrounding them), trimming this composite cuff to match the recipient’s atrium, and performing a straightforward running stitch. The approach has been used successfully with good graft function at one year and no evidence of narrowing at the connection site.²⁵ The technical challenge underscores a broader point: the pulmonary veins’ short length and variable anatomy make any surgical work in the area demanding, and pre-operative imaging to map the exact venous layout has become standard practice for transplant, ablation, and congenital repair alike.